Urabrelimab

Urabrelimab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76965-1mg 1 mg - - -

7 - 10 business days*

187.00€
TGM-T76965-10mg 10 mg - - -

7 - 10 business days*

878.00€
TGM-T76965-25mg 25 mg - - -

7 - 10 business days*

1,298.00€
TGM-T76965-50mg 50 mg - - -

7 - 10 business days*

1,754.00€
 
Description: Urabrelimab (SRF-231) is a humanized antibody targeting CD47, with antitumor... more
Product information "Urabrelimab"
Description: Urabrelimab (SRF-231) is a humanized antibody targeting CD47, with antitumor activity. It blocks the CD47-SIRPalpha interaction and is used in studies of advanced malignant solid tumors. Target: Interleukin, Others. References: Peluso MO, et al. The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a. J Immunother Cancer. 2020 Apr,8(1):e000413.
Keywords: SRF231 , SRF-231
Supplier: TargetMol
Supplier-Nr: T76965

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Urabrelimab"
Write a review
or to review a product.
Viewed